SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. You have free access to this content1
    D. Popovic, C. Torrent, J. M. Goikolea, N. Cruz, J. Sánchez-Moreno, A. González-Pinto, E. Vieta, Clinical implications of predominant polarity and the polarity index in bipolar disorder: a naturalistic study, Acta Psychiatrica Scandinavica, 2014, 129, 5
  2. 2
    Alexander McGirr, David J. Bond, Comprehensive Pharmacologic Management of Bipolar Depression, Current Treatment Options in Psychiatry, 2014, 1, 3, 263

    CrossRef

  3. 3
    Shih-Ku Lin, Efficacy of Long-acting, Injectable Antipsychotics in the Treatment of Bipolar Disorders, Journal of Experimental & Clinical Medicine, 2014, 6, 6, 200

    CrossRef

  4. 4
    Massimiliano Buoli, Marta Serati, A. Carlo Altamura, Is the combination of a mood stabilizer plus an antipsychotic more effective than mono-therapies in long-term treatment of bipolar disorder? A systematic review, Journal of Affective Disorders, 2014, 152-154, 12

    CrossRef

  5. 5
    Dong-Jing Fu, Cynthia A. Bossie, Jennifer Kern Sliwa, Yi-Wen Ma, Larry Alphs, Paliperidone Palmitate versus Risperidone Long-Acting Injection in Markedly-to-Severely Ill Schizophrenia Subjects, Clinical Schizophrenia & Related Psychoses, 2014, 8, 2, 101

    CrossRef

  6. 6
    Ludovic Samalin, Aurore Nourry, Thomas Charpeaud, Pierre-Michel Llorca, What is the evidence for the use of second-generation antipsychotic long-acting injectables as maintenance treatment in bipolar disorder?, Nordic Journal of Psychiatry, 2014, 68, 4, 227

    CrossRef

  7. 7
    Salvatore Gentile, Adverse Effects Associated with Second-Generation Antipsychotic Long-Acting Injection Treatment: A Comprehensive Systematic Review, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2013, 33, 10
  8. 8
    Lakshmi N Yatham, Sidney H Kennedy, Sagar V Parikh, Ayal Schaffer, Serge Beaulieu, Martin Alda, Claire O’Donovan, Glenda MacQueen, Roger S McIntyre, Verinder Sharma, Arun Ravindran, L Trevor Young, Roumen Milev, David J Bond, Benicio N Frey, Benjamin I Goldstein, Beny Lafer, Boris Birmaher, Kyooseob Ha, Willem A Nolen, Michael Berk, Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013, Bipolar Disorders, 2013, 15, 1
  9. You have free access to this content9
    Shigenobu Kanba, Tadafumi Kato, Takeshi Terao, Kazuo Yamada, Guideline for treatment of bipolar disorder by the Japanese Society of Mood Disorders, 2012, Psychiatry and Clinical Neurosciences, 2013, 67, 5
  10. 10
    Traci L. Turner, The use of antipsychotics in maintenance treatment of bipolar disorder, Mental Health Clinician, 2013, 2, 12, 412

    CrossRef

  11. 11
    Heinz Grunze, Eduard Vieta, Guy M. Goodwin, Charles Bowden, Rasmus W. Licht, Hans-Jürgen Möller, Siegfried Kasper, The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2012 on the long-term treatment of bipolar disorder, The World Journal of Biological Psychiatry, 2013, 14, 3, 154

    CrossRef

  12. 12
    Eduard Vieta, Stuart Montgomery, Ahmad Hatim Sulaiman, Rodrigo Cordoba, Benedicte Huberlant, Lupe Martinez, Andreas Schreiner, A randomized, double-blind, placebo-controlled trial to assess prevention of mood episodes with risperidone long-acting injectable in patients with bipolar I disorder, European Neuropsychopharmacology, 2012, 22, 11, 825

    CrossRef

  13. 13
    Berit X Carlson, Terence A Ketter, Wei Sun, Karen Timko, Robert D McQuade, Raymond Sanchez, Estelle Vester-Blokland, Ronald Marcus, Aripiprazole in combination with lamotrigine for the long-term treatment of patients with bipolar I disorder (manic or mixed): a randomized, multicenter, double-blind study (CN138-392), Bipolar Disorders, 2012, 14, 1
  14. 14
    Konstantinos N. Fountoulakis, Siegfried Kasper, Ole Andreassen, Pierre Blier, Ahmed Okasha, Emanuel Severus, Marcio Versiani, Rajiv Tandon, Hans-Jürgen Möller, Eduard Vieta, Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry, European Archives of Psychiatry and Clinical Neuroscience, 2012, 262, S1, 1

    CrossRef

  15. 15
    Alexandre Duarte Gigante, Beny Lafer, Lakshmi N. Yatham, Long-Acting Injectable Antipsychotics for the Maintenance Treatment of Bipolar Disorder, CNS Drugs, 2012, 26, 5, 403

    CrossRef

  16. 16
    Michael Gitlin, Mark A Frye, Maintenance therapies in bipolar disorders, Bipolar Disorders, 2012, 14,
  17. 17
    V. V. Dias, V. Balanzá-Martinez, M. G. Soeiro-de-Souza, R. A. Moreno, M. L. Figueira, R. Machado-Vieira, E. Vieta, Pharmacological approaches in bipolar disorders and the impact on cognition: a critical overview, Acta Psychiatrica Scandinavica, 2012, 126, 5
  18. 18
    Dina Popovic, Maria Reinares, Jose Manuel Goikolea, Caterina Mar Bonnin, Ana Gonzalez-Pinto, Eduard Vieta, Polarity index of pharmacological agents used for maintenance treatment of bipolar disorder, European Neuropsychopharmacology, 2012, 22, 5, 339

    CrossRef

  19. 19
    Konstantinos N. Fountoulakis, Refractoriness in Bipolar Disorder: Definitions and Evidence-Based Treatment, CNS Neuroscience & Therapeutics, 2012, 18, 3
  20. 20
    Textbook of Clinical Neuropsychiatry and Behavioral Neuroscience 3E, 2012,

    CrossRef

  21. 21
    William V. Bobo, Richard A. Epstein, Alan Lynch, Tynya D. Patton, Nicholas A. Bossaller, Richard C. Shelton, A Randomized Open Comparison of Long-Acting Injectable Risperidone and Treatment as Usual for Prevention of Relapse, Rehospitalization, and Urgent Care Referral in Community-Treated Patients With Rapid Cycling Bipolar Disorder, Clinical Neuropharmacology, 2011, 34, 6, 224

    CrossRef

  22. 22
    Wayne Macfadden, Caleb M Adler, Ibrahim Turkoz, John T Haskins, Norris Turner, Larry Alphs, Adjunctive long-acting risperidone in patients with bipolar disorder who relapse frequently and have active mood symptoms, BMC Psychiatry, 2011, 11, 1, 171

    CrossRef

  23. 23
    Eduard Vieta, Oliver Günther, Julie Locklear, Mattias Ekman, Carolin Miltenburger, Mary Lou Chatterton, Mikael Åström, Björn Paulsson, Effectiveness of psychotropic medications in the maintenance phase of bipolar disorder: a meta-analysis of randomized controlled trials, The International Journal of Neuropsychopharmacology, 2011, 14, 08, 1029

    CrossRef

  24. 24
    Dina Popovic, Maria Reinares, Benedikt Amann, Manel Salamero, Eduard Vieta, Number needed to treat analyses of drugs used for maintenance treatment of bipolar disorder, Psychopharmacology, 2011, 213, 4, 657

    CrossRef

  25. 25
    Steven L Dubovsky, Amelia N Dubovsky, Ziprasidone for maintenance treatment of bipolar I disorder in adults, Expert Opinion on Pharmacotherapy, 2011, 12, 5, 817

    CrossRef

  26. 26
    K. N. Roy Chengappa, Scott R. Turkin, Patricia J. Schlicht, Sherry L. Murphy, Jaspreet S. Brar, Andrea Fagiolini, Patricia R. Houck, Ronald G. Garbutt, Noreen Fredrick, A Pilot, 15-month, randomised effectiveness trial of Risperidone long-acting injection (RLAI) versus oral atypical antipsychotic agents (AAP) in persons with bipolar disorder, Acta Neuropsychiatrica, 2010, 22, 2
  27. 27
    Michael J. Gitlin, Osama Abulseoud, Mark A. Frye, Improving the design of maintenance studies for bipolar disorder, Current Medical Research and Opinion, 2010, 26, 8, 1835

    CrossRef

  28. 28
    Jorge A. Quiroz, Lakshmi N. Yatham, Joseph M. Palumbo, Keith Karcher, Stuart Kushner, Vivek Kusumakar, Risperidone Long-Acting Injectable Monotherapy in the Maintenance Treatment of Bipolar I Disorder, Biological Psychiatry, 2010, 68, 2, 156

    CrossRef

  29. 29
    Emma D. Deeks, Risperidone Long-Acting Injection, Drugs, 2010, 70, 8, 1001

    CrossRef

  30. 30
    L. Ivo Caers, Joris Berwaerts, Risperidone and Paliperidone in the Treatment of Bipolar Disorder,